Friday, November 21, 2014 12:46:29 PM
Fortunately, these compounding issues were to our benefit, as they allowed us to load up on this stock at undervalued prices. Even without forward-looking speculation and non-imaginative projections, the share price is still well below what it should be.
I believe that this trading season, which is only beginning, will bring a lot of exposure to this stock as any new eyes that come across this story will not allow it to leave their radar. There is no company that can compare to this in the OTC, so PXYN exposure will spread across the market to every trader's watchlist - especially with the help of the posters here, who have taken their time to do in-depth due diligence and are kind enough to share it here for all to see - with proof to support the facts.
Additionally, I believe we will also get increased exposure as promoters won't be able to resist dropping a line about PXYN - paid or not - just to say that they "alerted it" when it is still being talked about years from now.
PXYN
Branded Legacy Secures Exclusive Extraction Partnership with One of the World's Largest Kava Distributors and Producers • BLEG • May 30, 2024 8:30 AM
ECGI Holdings, Inc. Announces $2 Million Debt-to-Equity Conversion • ECGI • May 30, 2024 8:30 AM
North Bay Resources Reports Assays up to >25% Mg, 0.1% Ni, 0.1% Cu, 0.01% Co, 0.3 ppm Pt at Tulameen Platinum Project, British Columbia • NBRI • May 29, 2024 9:03 AM
One World Products, Inc. Issues Shareholder Update • OWPC • May 29, 2024 8:20 AM
Green Leaf Innovations, Inc. Engages Olayinka Oyebola & Co for Two-Year Audit • GRLF • May 28, 2024 8:30 AM
HealthLynked Introduces AI-Powered Chat Function to Enhance Healthcare Accessibility • HLYK • May 28, 2024 8:00 AM